BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 24284978)

  • 1. Implantable cardioverter-defibrillators in congenital heart disease.
    Mondésert B; Khairy P
    Curr Opin Cardiol; 2014 Jan; 29(1):45-52. PubMed ID: 24284978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ventricular arrhythmias and sudden cardiac death in adults with congenital heart disease.
    Khairy P
    Heart; 2016 Nov; 102(21):1703-1709. PubMed ID: 27250216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implantable cardioverter-defibrillator insertion in congenital heart disease without transvenous access to the heart.
    Nery PB; Green MS; Khairy P; Alhebaishi Y; Hendry P; Birnie DH
    Can J Cardiol; 2013 Feb; 29(2):254.e1-3. PubMed ID: 22749646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of implantable cardioverter defibrillators in adults with congenital heart disease: a multi-centre study.
    Yap SC; Roos-Hesselink JW; Hoendermis ES; Budts W; Vliegen HW; Mulder BJ; van Dijk AP; Schalij MJ; Drenthen W
    Eur Heart J; 2007 Aug; 28(15):1854-61. PubMed ID: 17030523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implantable cardioverter defibrillator therapy in paediatric practice: a single-centre UK experience with focus on subcutaneous defibrillation.
    Griksaitis MJ; Rosengarten JA; Gnanapragasam JP; Haw MP; Morgan JM
    Europace; 2013 Apr; 15(4):523-30. PubMed ID: 23333943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implantable cardioverter-defibrillator shocks: epidemiology, outcomes, and therapeutic approaches.
    Borne RT; Varosy PD; Masoudi FA
    JAMA Intern Med; 2013 May; 173(10):859-65. PubMed ID: 23546173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcutaneous Implantable Cardioverter Defibrillators in Pediatrics and Congenital Heart Disease.
    Kohli U; von Alvensleben J; Srinivasan C
    Card Electrophysiol Clin; 2023 Dec; 15(4S):e1-e16. PubMed ID: 38030336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implantable cardioverter-defibrillators in congenital heart disease.
    Chubb H; Rosenthal E
    Herzschrittmacherther Elektrophysiol; 2016 Jun; 27(2):95-103. PubMed ID: 27250725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implantable cardioverter-defibrillators in children.
    Blom NA
    Pacing Clin Electrophysiol; 2008 Feb; 31 Suppl 1():S32-4. PubMed ID: 18226032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcutaneous Implantable Cardioverter-Defibrillators in Patients With Congenital Heart Disease.
    Waldmann V; Marquié C; Bessière F; Perrot D; Anselme F; Badenco N; Barra S; Bertaux G; Blangy H; Bordachar P; Boveda S; Chauvin M; Clémenty N; Clerici G; Combes N; Defaye P; Deharo JC; Durand P; Duthoit G; Eschalier R; Fauchier L; Garcia R; Geoffroy O; Gitenay E; Gourraud JB; Guenancia C; Iserin L; Jacon P; Jesel-Morel L; Kerkouri F; Klug D; Koutbi L; Labombarda F; Ladouceur M; Laurent G; Leclercq C; Maille B; Maltret A; Massoulié G; Mondoly P; Ninni S; Ollitrault P; Pasquié JL; Pierre B; Pujadas P; Champ-Rigot L; Sacher F; Sadoul N; Schatz A; Winum P; Milliez PU; Probst V; Marijon E
    J Am Coll Cardiol; 2023 Aug; 82(7):590-599. PubMed ID: 37558371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-center experience with implantable cardioverter-defibrillators in adults with complex congenital heart disease.
    Khanna AD; Warnes CA; Phillips SD; Lin G; Brady PA
    Am J Cardiol; 2011 Sep; 108(5):729-34. PubMed ID: 21684513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale and design of the OPTION study: optimal antitachycardia therapy in ICD patients without pacing indications.
    Kolb C; Tzeis S; Sturmer M; Babuty D; Schwab JO; Mantovani G; Janko S; Aimé E; Ocklenburg R; Sick P
    Pacing Clin Electrophysiol; 2010 Sep; 33(9):1141-8. PubMed ID: 20487351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should patients with congenital heart disease and a systemic ventricular ejection fraction less than 30% undergo prophylactic implantation of an ICD? Patients with congenital heart disease and a systemic ventricular ejection fraction less than 30% should undergo prophylactic implantation of an implantable cardioverter defibrillator.
    Silka MJ; Bar-Cohen Y
    Circ Arrhythm Electrophysiol; 2008 Oct; 1(4):298-306. PubMed ID: 19808422
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of transvenous implantable cardioverter-defibrillators in preventing sudden cardiac death in children, adolescents, and young adults.
    Chatrath R; Porter CB; Ackerman MJ
    Mayo Clin Proc; 2002 Mar; 77(3):226-31. PubMed ID: 11888025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experience of entirely subcutaneous implantable cardioverter-defibrillators in children and adults: cause for caution.
    Jarman JW; Lascelles K; Wong T; Markides V; Clague JR; Till J
    Eur Heart J; 2012 Jun; 33(11):1351-9. PubMed ID: 22408031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implantable cardioverter-defibrillators and patient-reported outcomes in adults with congenital heart disease: An international study.
    Lévesque V; Laplante L; Shohoudi A; Apers S; Kovacs AH; Luyckx K; Thomet C; Budts W; Enomoto J; Sluman MA; Lu CW; Jackson JL; Cook SC; Chidambarathanu S; Alday L; Eriksen K; Dellborg M; Berghammer M; Johansson B; Mackie AS; Menahem S; Caruana M; Veldtman G; Soufi A; Fernandes SM; White K; Callus E; Kutty S; Brouillette J; Casteigt B; Moons P; Khairy P;
    Heart Rhythm; 2020 May; 17(5 Pt A):768-776. PubMed ID: 31790832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of implantable cardioverter-defibrillators in patients with Chagas disease.
    Barbosa MP; da Costa Rocha MO; de Oliveira AB; Lombardi F; Ribeiro AL
    Europace; 2013 Jul; 15(7):957-62. PubMed ID: 23376978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should patients with congenital heart disease and a systemic ventricular ejection fraction less than 30% undergo prophylactic implantation of an ICD? Implantable cardioverter defibrillator implantation guidelines based solely on left ventricular ejection fraction do not apply to adults with congenital heart disease.
    Triedman JK
    Circ Arrhythm Electrophysiol; 2008 Oct; 1(4):307-16; discussion 316. PubMed ID: 19808423
    [No Abstract]   [Full Text] [Related]  

  • 19. Potential eligibility of congenital heart disease patients for subcutaneous implantable cardioverter-defibrillator based on surface electrocardiogram mapping.
    Zeb M; Curzen N; Veldtman G; Yue A; Roberts P; Wilson D; Morgan J
    Europace; 2015 Jul; 17(7):1059-67. PubMed ID: 25678600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical techniques for implanting implantable cardioverter defibrillators in children and infants.
    Suzuki S; Motohashi S; Matsumoto M
    Surg Today; 2014 Oct; 44(10):1801-6. PubMed ID: 24154922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.